{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:14:43Z","timestamp":1761192883668,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijid.2025.108073","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:37:08Z","timestamp":1758591428000},"page":"108073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prophylaxis followed by preemptive approach versus prophylaxis to prevent CMV infection in CMV-seropositive kidney transplant recipients receiving anti-thymocyte globulin induction therapy"],"prefix":"10.1016","volume":"160","author":[{"given":"Theerapong","family":"Rattnaruangsup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungthiwa","family":"Kitpermkiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0930-8936","authenticated-orcid":false,"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108073_bib0001","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014guidelines of the American society of transplantation infectious diseases community of practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2025.108073_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.tp.0000183970.71366.da","article-title":"Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"81","author":"Strippoli","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2025.108073_bib0004","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2025.108073_bib0005","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1432-2277.2011.01321.x","article-title":"The risk of cytomegalovirus recurrence after kidney transplantation","volume":"24","author":"Helanter\u00e4","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.ijid.2025.108073_bib0006","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2025.108073_bib0008","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/cid\/ciab574","article-title":"Immunoguided discontinuation of prophylaxis for cytomegalovirus disease in kidney transplant recipients treated with antithymocyte globulin: A randomized clinical trial","volume":"74","author":"P\u00e1ez-Vega","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108073_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2025.108073_bib0010","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.TP.0000145989.22373.03","article-title":"Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis","volume":"78","author":"Limaye","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2025.108073_bib0011","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14379","article-title":"Valganciclovir prophylaxis extension from 3 to 6 months in high-risk pancreas transplant recipients does not impact incidence of cytomegalovirus infection at 12 months","volume":"35","author":"Jorgenson","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0012","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: A single-center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2025.108073_bib0013","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R\u2212 kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.ijid.2025.108073_bib0014","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.transproceed.2021.07.031","article-title":"Selection of more vulnerable patients for cytomegalovirus infection in renal transplant recipients with antithymocyte globulin induction therapy: an analysis of risk factors and cell-mediated immunity","volume":"53","author":"Jun","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2025.108073_bib0015","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1600-6143.2009.02672.x","article-title":"Adoptive T-cell therapy of a lung-transplanted patient with severe CMV disease and resistance to antiviral therapy","volume":"9","author":"Brestrich","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0016","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0017","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.transproceed.2015.08.011","article-title":"Risk factors of cytomegalovirus disease in kidney transplant recipients: A single-center study in Thailand","volume":"47","author":"Chiasakul","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2025.108073_bib0018","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijid.2025.108073_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.893232","article-title":"QuantiFERON-Cytomegalovirus assay for prediction of cytomegalovirus viremia in kidney transplant recipients: study from a high cytomegalovirus seroprevalence country","volume":"12","author":"Pongsakornkullachart","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.ijid.2025.108073_bib0020","doi-asserted-by":"crossref","first-page":"ofz322","DOI":"10.1093\/ofid\/ofz322","article-title":"A Nationwide Survey of cytomegalovirus prevention strategies in kidney transplant recipients in a resource-limited setting","volume":"6","author":"Bruminhent","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:12:57Z","timestamp":1761192777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225002954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":20,"alternative-id":["S1201971225002954"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108073","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylaxis followed by preemptive approach versus prophylaxis to prevent CMV infection in CMV-seropositive kidney transplant recipients receiving anti-thymocyte globulin induction therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108073"}}